| Characteristic | Number of employees |
|---|---|
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
The chart is not accessible to screen readers. Please switch to the table view to access the data.
Download
Source
Sources
Release date
March 2025
More information
Region
Worldwide, Germany
Survey time period
1999 to 2024
Supplementary notes
The company Merck KGaA operates under the umbrella brand EMD (Millipore) in North America.
* The Generics division was divested in October 2007. All revenue, profit and employee numbers have been adjusted for 2006 and 2007.
** 2007: Following the acquisition of the Swiss biopharmaceutical company Serono, the company has been added to Merck under the Ethicals division.
All figures are valid as of December 31 of each year.
This statistic was assembled from several publications of the same source.
Citation formats
